OPK
USDOPKO Health Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$1.370
고가
$1.430
저가
$1.370
거래량
2.69M
기업 기본 정보
시가총액
1.1B
산업
Diagnostics & Research
국가
United States
거래 통계
평균 거래량
2.21M
거래소
NMS
통화
USD
52주 범위
관련 뉴스
Jefferies Downgrades OPKO Health to Hold, Lowers Price Target to $1.6
Jefferies analyst Maury Raycroft downgrades OPKO Health from Buy to Hold and lowers the price target from $2 to $1.6.
Barrington Research Maintains Outperform on OPKO Health, Maintains $2.25 Price Target
Barrington Research analyst Michael Petusky maintains OPKO Health with a Outperform and maintains $2.25 price target.
OPKO Health's ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications
Potential assets would target multiple biological pathways in a single molecule Total value of the partnership potentially exceeds $1 billion if multiple assets advance WESTON, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) --
OPKO Health's ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers
First patient dosed in Phase 1/2a study with novel immune rejuvenator, a trispecific antibody-fusion protein Two MDX2004 abstracts accepted for poster presentation at SITC Annual Meeting 2025 WESTON, Mass., Oct. 28,
OPKO Health to Report Third Quarter 2025 Financial Results on October 29
MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ:OPK) plans to report operating and financial results for the three and nine months ended September 30, 2025 after the close of the U.S. financial
관련 주식
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기